Clinical Trial Update: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism [Phase 2]

View source ↗

Summary

A National Cancer Institute-sponsored Phase 2 trial comparing adrenalectomy versus observation for subclinical hypercortisolism/Cushing syndrome was terminated;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Neoplasm
• Cushing Syndrome
• Subclinical Hypercortisolism

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Subclinical Hypercortisolism, Cushing Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2018-05-08